These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22484715)

  • 1. The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
    Takiguchi S; Nishino Y; Inoue K; Ikeda M; Kataoka Y; Matsusue K; Nishiyama K; Iguchi H
    Oncol Rep; 2012 Jul; 28(1):111-6. PubMed ID: 22484715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model.
    Hashimoto K; Morishige K; Sawada K; Tahara M; Kawagishi R; Ikebuchi Y; Sakata M; Tasaka K; Murata Y
    Cancer Res; 2005 Jan; 65(2):540-5. PubMed ID: 15695397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
    J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
    Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
    Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
    Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
    Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial chemotherapy with ricin-loaded thermosensitive hydrogel in pancreatic cancer xenograft.
    Chen ZK; Lin LW; Weng XH; Xue ES; Lin YH
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):418-23. PubMed ID: 19666413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer.
    Kim CE; Lim SK; Kim JS
    J Control Release; 2012 Jan; 157(2):190-5. PubMed ID: 21963773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers.
    Gründker C; Ernst J; Reutter MD; Ghadimi BM; Emons G
    Oncol Rep; 2011 Sep; 26(3):629-35. PubMed ID: 21667032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.
    Wang Z; Li XM; Shang K; Zhang P; Wang CF; Xin YH; Zhou L; Li YY
    Oncol Rep; 2013 Mar; 29(3):1245-51. PubMed ID: 23314349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
    Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
    Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer.
    Schlingensiepen KH; Jaschinski F; Lang SA; Moser C; Geissler EK; Schlitt HJ; Kielmanowicz M; Schneider A
    Cancer Sci; 2011 Jun; 102(6):1193-200. PubMed ID: 21366804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
    Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination paclitaxel and inhibitor of nuclear factor κB activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancer.
    Fujiwara Y; Furukawa K; Shimada Y; Iida T; Shiba H; Uwagawa T; Misawa T; Ohashi T; Yanaga K
    Pancreas; 2011 May; 40(4):600-7. PubMed ID: 21343836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of α-bisabolol against pancreatic cancer.
    Seki T; Kokuryo T; Yokoyama Y; Suzuki H; Itatsu K; Nakagawa A; Mizutani T; Miyake T; Uno M; Yamauchi K; Nagino M
    Cancer Sci; 2011 Dec; 102(12):2199-205. PubMed ID: 21883695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.